Figure 5.
Efficacy in tolerance induction and maintenance between 1–102-IgG and 1–102 gene transfer. (A) LPS blast recipients. (B) BM recipients. (Upper) Primary immune response. (Lower) Secondary immune response.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.